Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihaela C Cristea

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Left atrial massMihaela C Cristea, Kalyanasundaram Venkataraman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2011
Osteonecrosis of the humeral head in a patient with non-small cell lung cancer receiving bevacizumabMarianna Koczywas, Mihaela C Cristea
Cancer Genetics|March 21, 2012
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survivalJoyce Liu, Mihaela C Cristea, Paul Frankel, et al.
Cancer|June 3, 2015
Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancerKaren L Reckamp, Marianna Koczywas, Mihaela C Cristea, et al.
BMC Cancer|January 17, 2013
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumorsJoseph P Connor, Mihaela C Cristea, Nancy L Lewis, et al.
Frontiers in Oncology|March 28, 2019
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (<i>EGFR</i>)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)Karen L Reckamp, Paul H Frankel, Nora Ruel, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2019
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavityMihaela C Cristea, Paul Frankel, Timothy Synold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian CancerLarissa A Meyer, Angel M Cronin, Charlotte C Sun, et al.
Gynecologic Oncology|January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancerMihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2018
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumorsStephen V Liu, Susan G Groshen, Karen Kelly, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Left atrial massMihaela C Cristea, Kalyanasundaram Venkataraman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2011
Osteonecrosis of the humeral head in a patient with non-small cell lung cancer receiving bevacizumabMarianna Koczywas, Mihaela C Cristea
Cancer Genetics|March 21, 2012
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survivalJoyce Liu, Mihaela C Cristea, Paul Frankel, et al.
Cancer|June 3, 2015
Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancerKaren L Reckamp, Marianna Koczywas, Mihaela C Cristea, et al.
BMC Cancer|January 17, 2013
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumorsJoseph P Connor, Mihaela C Cristea, Nancy L Lewis, et al.
Frontiers in Oncology|March 28, 2019
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (<i>EGFR</i>)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)Karen L Reckamp, Paul H Frankel, Nora Ruel, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2019
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavityMihaela C Cristea, Paul Frankel, Timothy Synold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian CancerLarissa A Meyer, Angel M Cronin, Charlotte C Sun, et al.
Gynecologic Oncology|January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancerMihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2018
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumorsStephen V Liu, Susan G Groshen, Karen Kelly, et al.
Pageof 3